187 related articles for article (PubMed ID: 27488202)
1. Rapid reduction of antibodies and improvement of disease activity by immunoadsorption in Chinese patients with severe systemic lupus erythematosus.
Huang J; Song G; Yin Z; He W; Zhang L; Kong W; Ye Z
Clin Rheumatol; 2016 Sep; 35(9):2211-8. PubMed ID: 27488202
[TBL] [Abstract][Full Text] [Related]
2. IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study.
Stummvoll GH; Aringer M; Smolen JS; Schmaldienst S; Jiménez-Boj E; Hörl WH; Graninger WB; Derfler K
Ann Rheum Dis; 2005 Jul; 64(7):1015-21. PubMed ID: 15640267
[TBL] [Abstract][Full Text] [Related]
3. Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacy.
Stummvoll GH; Aringer M; Jansen M; Smolen JS; Derfler K; Graninger WB
Wien Klin Wochenschr; 2004 Nov; 116(21-22):716-24. PubMed ID: 15628641
[TBL] [Abstract][Full Text] [Related]
4. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.
Fanouriakis A; Adamichou C; Koutsoviti S; Panopoulos S; Staveri C; Klagou A; Tsalapaki C; Pantazi L; Konsta S; Mavragani CP; Dimopoulou D; Ntali S; Katsikas G; Boki KA; Vassilopoulos D; Konstantopoulou P; Liossis SN; Elezoglou A; Tektonidou M; Sidiropoulos P; Erden A; Sfikakis PP; Bertsias G; Boumpas DT
Semin Arthritis Rheum; 2018 Dec; 48(3):467-474. PubMed ID: 29555348
[TBL] [Abstract][Full Text] [Related]
5. Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity.
Stummvoll GH; Schmaldienst S; Smolen JS; Derfler K; Biesenbach P
Nephrol Dial Transplant; 2012 Feb; 27(2):618-26. PubMed ID: 21617196
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.
Ale'ed A; Alsonbul A; Al-Mayouf SM
Rheumatol Int; 2014 Apr; 34(4):529-33. PubMed ID: 24218286
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy comparison of HA280 and DNA280 immunoadsorption column in treating systemic lupus erythematosus.
Xu L; Wu X; Zou Y
Mod Rheumatol; 2016; 26(1):94-8. PubMed ID: 26025438
[TBL] [Abstract][Full Text] [Related]
8. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.
Yahya F; Jasmin R; Ng CT; Cheah TE; Sockalingam S
Int J Rheum Dis; 2013 Dec; 16(6):724-30. PubMed ID: 24119227
[TBL] [Abstract][Full Text] [Related]
9. [Use of plasmapheresis in therapy of systemic lupus erythematosus: a controlled study].
Zielinski C; Müller C; Smolen J
Acta Med Austriaca; 1988; 15(5):155-8. PubMed ID: 3064527
[TBL] [Abstract][Full Text] [Related]
10. Immunoadsorption for systemic lupus erythematosus.
Stummvoll GH; Julius U; Derfler K; Aringer M
Atheroscler Suppl; 2009 Dec; 10(5):110-3. PubMed ID: 20129387
[TBL] [Abstract][Full Text] [Related]
11. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study.
Wallace DJ; Hobbs K; Clowse ME; Petri M; Strand V; Pike M; Merrill JT; Leszczyński P; Neuwelt CM; Jeka S; Houssiau F; Keiserman M; Ordi-Ros J; Bongardt S; Kilgallen B; Galateanu C; Kalunian K; Furie R; Gordon C
Arthritis Care Res (Hoboken); 2016 Apr; 68(4):534-43. PubMed ID: 26316325
[TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
[TBL] [Abstract][Full Text] [Related]
14. Lupus mesenteric vasculitis: clinical features and associated factors for the recurrence and prognosis of disease.
Yuan S; Ye Y; Chen D; Qiu Q; Zhan Z; Lian F; Li H; Liang L; Xu H; Yang X
Semin Arthritis Rheum; 2014 Jun; 43(6):759-66. PubMed ID: 24332116
[TBL] [Abstract][Full Text] [Related]
15. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
[TBL] [Abstract][Full Text] [Related]
16. Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen.
Ezeonyeji AN; Isenberg DA
Rheumatology (Oxford); 2012 Mar; 51(3):476-81. PubMed ID: 22096015
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response.
Jónsdóttir T; Gunnarsson I; Risselada A; Henriksson EW; Klareskog L; van Vollenhoven RF
Ann Rheum Dis; 2008 Mar; 67(3):330-4. PubMed ID: 17827182
[TBL] [Abstract][Full Text] [Related]
18. Immunoadsorption (IAS) for systemic lupus erythematosus.
Stummvoll GH
Lupus; 2011 Feb; 20(2):115-9. PubMed ID: 21303827
[TBL] [Abstract][Full Text] [Related]
19. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
Joo YB; Bae SC
Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
[TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study.
Li QY; Yu F; Zhou FD; Zhao MH
Medicine (Baltimore); 2016 May; 95(18):e3595. PubMed ID: 27149490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
